Back to Agendas
CFAST Initiative: Potential to Dramatically Increase ROI and Reduce Timelines in the Conduct of Clinical Trials
Session Chair(s)
Diane E. Wold, PhD
Director, Concept Modeling, CDISC, United States
The Coalition for Accelerating Standards and Therapies (CFAST) initiative has made progress in increasing the speed and number of therapeutic area (TA) standards developed. These accomplishments have the potential to dramatically increase return on investment and reduce the timeline in the conduct of clinical trials.
Learning Objective : Describe the CFAST initiative including the potential benefit of developing therapeutic area (TA) standards; Discuss the new regulatory environment including how standards are being increasingly adopted; Identify how TA standards can benefit your organization.
Speaker(s)
Recent FDA Guidance on Data Standards and CDISC Activities
Ron Fitzmartin, MBA
Principal Consultant, Decision Analytics, United States
CFAST: Innovative Approaches to Standards Development and ROI These Standards Can Facilitate
Diane E. Wold, PhD
Director, Concept Modeling, CDISC, United States
Maximizing The Value of Data Through Collaboration
Enrique Aviles
Chief Technology Officer, Critical Path Institute, United States
Have an account?